Qualigen Therapeutics Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Qualigen Therapeutics, Inc. is a clinical-stage biotechnology company based in Carlsbad, California, focused on developing cancer therapies for adults and children. The company operates within biotechnology research and has the potential for Orphan Drug Designation for its treatments. It is publicly traded on Nasdaq under the ticker QLGN. Its focus on cancers with high unmet medical need places it squarely in the oncology segment of biotechnology research. As a clinical-stage, smaller biotechnology company, Qualigen Therapeutics operates with a research-driven mandate aimed at advancing cancer therapies.